Ultrasound-guided erector spinae plane block for postoperative analgesia in patients undergoing minimally invasive direct coronary artery bypass surgery: a double-blinded randomized controlled trial

Can J AnaesthPublished Randomised controlled trial

Authors' conclusion

Erector spinae plane block provided early effective postoperative analgesia and reduced opioid consumption, time to extubation, and ICU discharge in patients undergoing MIDCAB.

Study context

Population
Patients undergoing minimally invasive direct coronary artery bypass (MIDCAB) surgery
Participants
60 patients
Comparison
Single-shot ESP block with ropivacaine vs normal saline
  • Erector spinae plane block (ESPB)n = 30
  • Controln = 30reference
Primary endpoint
Numerical rating scale (NRS) pain scores at rest
Follow-up
Within 48 hr postoperatively
Methodological detailsdouble-blinded
  • Double-blinded

Primary result

As reported in the abstract

NRS pain at rest
ESPB vs ControlEstimated mean difference (99% CI)P value
6 hr
−2.1(−2.7 to −1.5)
P < 0.001
12 hr
−1.9(−2.6 to −1.2)
P < 0.001
18 hr
−1.2(−1.8 to −0.6)
P < 0.001

Secondary outcomes

OutcomeEstimated mean difference (99% CI)P value
NRS pain on deep inspirationESPB vs Control · 6 hr−2.9 (−3.6 to −2.1)P < 0.001
NRS pain on deep inspirationESPB vs Control · 12 hr−2.3 (−3.1 to −1.5)P < 0.001
NRS pain on deep inspirationESPB vs Control · 18 hr−1.0 (−1.8 to −0.2)P = 0.01

Opioid use, time to extubation, time to intensive care unit (ICU) discharge

ESPB: lower total intraoperative fentanyl use, lower 24-hr hydromorphone consumption, shorter time to extubation and to ICU discharge

Original publication

Ultrasound-guided erector spinae plane block for postoperative analgesia in patients undergoing minimally invasive direct coronary artery bypass surgery: a double-blinded randomized controlled trial. Can J Anaesth. Published 21 November 2023. doi:10.1007/s12630-023-02637-6

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.